Amedeo Smart

Free Medical Literature Service


 

Amedeo

Bladder Cancer

  Free Subscription

21.08.2017

1 Bioconjug Chem
1 Biomed Res Int
1 BJU Int
1 BMJ Open
2 Clin Cancer Res
1 Crit Rev Oncol Hematol
1 Environ Sci Pollut Res Int
1 Eur Urol
1 Indian J Clin Biochem
1 J Cell Biochem
1 J Int Med Res
1 J Magn Reson Imaging
1 J Membr Biol
1 J Occup Med Toxicol
1 Mol Biol Rep
2 Nat Rev Urol
2 Radiat Oncol
1 Surg Oncol
1 Surgery
1 Urol Oncol



    Bioconjug Chem

  1. LEE Y, Kischuk E, Crist S, Ratliff TL, et al
    Targeting and Internalization of Liposomes by Bladder Tumor Cells Using a Fibronectin Attachment Protein-Derived Peptide-Lipopolymer Conjugate.
    Bioconjug Chem. 2017;28:1481-1490.
    >> Share


    Biomed Res Int

  2. AVITAN O, Bahouth Z, Halachmi S, Shprits S, et al
    Histopathologic Differences between Jewish and Arab Population in Israel at First-Time Presentation with Bladder Cancer.
    Biomed Res Int. 2017;2017:8239601.
    >> Share


    BJU Int

  3. DUDDERIDGE T
    Positive messages for bladder cancer management in negative sentinel lymph node study.
    BJU Int. 2017;120:302-303.
    >> Share


    BMJ Open

  4. OUGHTON JB, Poad H, Twiddy M, Collinson M, et al
    Radical cystectomy (bladder removal) against intravesical BCG immunotherapy for high-risk non-muscle invasive bladder cancer (BRAVO): a protocol for a randomised controlled feasibility study.
    BMJ Open. 2017;7:e017913.
    >> Share


    Clin Cancer Res

  5. ZENG S, Zhu Y, Ma AH, Yu W, et al
    The Phosphatidylinositol 3-kinase Pathway as a Potential Therapeutic Target in Bladder Cancer.
    Clin Cancer Res. 2017 Aug 14. pii: clincanres.0033.2017.
    >> Share

  6. KATES M, Date A, Yoshida T, Afzal U, et al
    Preclincial Evaluation of Intravesical Cisplatin Nanoparticles for Non-Muscle-Invasive Bladder Cancer.
    Clin Cancer Res. 2017 Aug 14. pii: clincanres.1082.2017.
    >> Share


    Crit Rev Oncol Hematol

  7. CORMIO A, Sanguedolce F, Musicco C, Pesce V, et al
    Mitochondrial dysfunctions in bladder cancer: Exploring their role as disease markers and potential therapeutic targets.
    Crit Rev Oncol Hematol. 2017;117:67-72.
    >> Share


    Environ Sci Pollut Res Int

  8. FEKI-TOUNSI M, Khlifi R, Louati I, Fourati M, et al
    Polymorphisms in XRCC1, ERCC2, and ERCC3 DNA repair genes, CYP1A1 xenobiotic metabolism gene, and tobacco are associated with bladder cancer susceptibility in Tunisian population.
    Environ Sci Pollut Res Int. 2017 Aug 12. doi: 10.1007/s11356-017-9767.
    >> Share


    Eur Urol

  9. LEOW JJ, Cole AP, Seisen T, Bellmunt J, et al
    Variations in the Costs of Radical Cystectomy for Bladder Cancer in the USA.
    Eur Urol. 2017 Aug 9. pii: S0302-2838(17)30640.
    >> Share


    Indian J Clin Biochem

  10. VERMA A, Kapoor R, Mittal RD
    Genetic Variation in CD166 Gene and Its Association with Bladder Cancer Risk in North Indian Population.
    Indian J Clin Biochem. 2017;32:292-300.
    >> Share


    J Cell Biochem

  11. WANG Y, Zhang H, Li X, Chen W, et al
    Differential expression profile analysis of lncRNA UCA1alpha regulated mRNAs in bladder cancer.
    J Cell Biochem. 2017 Aug 16. doi: 10.1002/jcb.26345.
    >> Share


    J Int Med Res

  12. GERULLIS H, Ecke TH, Barski D, Bantel C, et al
    Retrospective analysis of a surgical innovation using the IDEAL framework: radical cystectomy with epidural anaesthesia.
    J Int Med Res. 2017;45:714-722.
    >> Share


    J Magn Reson Imaging

  13. WANG F, Wu LM, Hua XL, Zhao ZZ, et al
    Intravoxel incoherent motion diffusion-weighted imaging in assessing bladder cancer invasiveness and cell proliferation.
    J Magn Reson Imaging. 2017 Aug 17. doi: 10.1002/jmri.25839.
    >> Share


    J Membr Biol

  14. GECIT I, Eryilmaz R, Kavak S, Meral I, et al
    The Prolidase Activity, Oxidative Stress, and Nitric Oxide Levels of Bladder Tissues with or Without Tumor in Patients with Bladder Cancer.
    J Membr Biol. 2017 Aug 16. doi: 10.1007/s00232-017-9971.
    >> Share


    J Occup Med Toxicol

  15. MASTRANGELO G, Carta A, Arici C, Pavanello S, et al
    An etiologic prediction model incorporating biomarkers to predict the bladder cancer risk associated with occupational exposure to aromatic amines: a pilot study.
    J Occup Med Toxicol. 2017;12:23.
    >> Share


    Mol Biol Rep

  16. HUSSEIN S, Mosaad H, Rashed HE, Ahmed S, et al
    Molecular factors regulating E-cadherin expression in urothelial bladder cancer and their correlations with the clinicopathological features.
    Mol Biol Rep. 2017 Aug 14. doi: 10.1007/s11033-017-4118.
    >> Share


    Nat Rev Urol

  17. THOMA C
    Bladder cancer: The promise of liquid biopsy ctDNA analysis.
    Nat Rev Urol. 2017 Aug 16. doi: 10.1038/nrurol.2017.
    >> Share

  18. LOPEZ-BELTRAN A, Cheng L, Montorsi F, Scarpelli M, et al
    Concomitant bladder cancer and prostate cancer: challenges and controversies.
    Nat Rev Urol. 2017 Aug 16. doi: 10.1038/nrurol.2017.
    >> Share


    Radiat Oncol

  19. KRENGLI M, Pisani C, Deantonio L, Surico D, et al
    Intraoperative radiotherapy in gynaecological and genito-urinary malignancies: focus on endometrial, cervical, renal, bladder and prostate cancers.
    Radiat Oncol. 2017;12:18.
    >> Share

  20. NISHIOKA K, Shimizu S, Shinohara N, Ito YM, et al
    Analysis of inter- and intra fractional partial bladder wall movement using implanted fiducial markers.
    Radiat Oncol. 2017;12:44.
    >> Share


    Surg Oncol

  21. SHIGETA K, Kikuchi E, Hagiwara M, Ando T, et al
    Prolonged pneumoperitoneum time is an independent risk factor for intravesical recurrence after laparoscopic radical nephroureterectomy in upper tract urothelial carcinoma.
    Surg Oncol. 2017;26:73-79.
    >> Share


    Surgery

  22. ROIFE D, Kang Y, Wang L, Fang B, et al
    Generation of patient-derived xenografts from fine needle aspirates or core needle biopsy.
    Surgery. 2017;161:1246-1254.
    >> Share


    Urol Oncol

  23. STEINBERG RL, Nepple KG, Velaer KN, Thomas LJ, et al
    Quadruple immunotherapy of Bacillus Calmette-Guerin, interferon, interleukin-2, and granulocyte-macrophage colony-stimulating factor as salvage therapy for non-muscle-invasive bladder cancer.
    Urol Oncol. 2017 Aug 8. pii: S1078-1439(17)30386.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016